Colorcon Launches On-Dose Authentication Technology Platform
Counterfeit drugs are a major problem for the pharmaceutical industry, both in terms of financial impact and compromising on patient safety.
The illicit drug supply industry is estimated to be worth US$200 billion or 2% of total pharma revenue. Traceability and security measures focused at the packaging level are not enough to deter fraud; especially in low- and middle-income countries where either substandard or falsified medicines can account for up to 70% of medications distributed internally. The solution is smart medications with on-dose taggants that can be authenticated throughout the supply chain.
SoteriaRx on-dose authentication is a new tool for tracking medicines from plant to patient and provides a level of supply chain authenticity and transparency not previously available. By incorporating microtags, the pill itself effectively becomes a barcode which can be digitally read and recorded, providing instant authentication.
The illicit drug supply industry is estimated to be worth US$200 billion or 2% of total pharma revenue. Traceability and security measures focused at the packaging level are not enough to deter fraud; especially in low- and middle-income countries where either substandard or falsified medicines can account for up to 70% of medications distributed internally. The solution is smart medications with on-dose taggants that can be authenticated throughout the supply chain.
SoteriaRx on-dose authentication is a new tool for tracking medicines from plant to patient and provides a level of supply chain authenticity and transparency not previously available. By incorporating microtags, the pill itself effectively becomes a barcode which can be digitally read and recorded, providing instant authentication.
No comments: